The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis

BACKGROUND: The role of adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) is not clear in early‐stage nonsmall‐cell lung cancer (NSCLC) patients. This meta‐analysis aims to compare the efficacy and safety of EGFR‐TKIs as adjuvant therapy with chemotherapy or placebo in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thorac Cancer
Main Authors: Lin, Chutong, Hu, Fengling, Chu, Hongling, Ren, Peng, Ma, Shanwu, Wang, Jingdi, Bai, Jie, Han, Xuan, Ma, Shaohua
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons Australia, Ltd 2021
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017245/
https://ncbi.nlm.nih.gov/pubmed/33660941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13874
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker